CCRB Logo

Trial History Detail on 2012-08-31

CUHK_CCT00061

2005-09-09

Retrospective

NONE

NONE

NONE

Chan Yat Sun Joseph

Prince of Wales Hospital, The Chinese University of Hong Kong

jyschan@cuhk.edu.hk

Chan Yat Sun Joseph

Prince of Wales Hospital, The Chinese University of Hong Kong

jyschan@cuhk.edu.hk

Myocardial Protection with Glucose-Insulin-Potassium (GIK) in Patients Undergoing Percutaneous Coronary Interventions

Yes

2003-01-06

Heart and Blood Vessel Diseases

Procedure

Glucose-Insulin-Potassium during Percutaneous Coronary Intervention (PCI)

Few hours

Placebo

Inclusion: Patients undergoing elective PCI with normal, static or decreasing level of troponin levl

Exclusion Patients undergoing direct PCI for ST elevation myocardial infarction Patients on regular insuli therapy Patients with uncorrected hypokalaemia, hyperkalaemia, hypoglycemia or hyperglycemia Patients with rising level of troponin Patients with creatine level > 250

Randomized

Placebo

Open label

Single group

2003-03-03

500

Unknown

Troponin rise after PCI

Composite endpoint of 30 days major cardiovascular events post PCI

No

2011-04-01

ChiCTR-TRC-09000653

2010-05-04


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.